Highline Wealth Partners
RMD icon

Highline Wealth Partners’s ResMed RMD Stock Holding History

Highline Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.19K Hold
28
– – ﹤0.01% 849
2026
Q2 		$5.46K Buy
28
+20
+250% +$4.14K ﹤0.01% 836
2026
Q1 		$1.8K Sell
8
-1
-11% -$249 ﹤0.01% 1080
2025
Q4 		$2.17K Sell
9
-1
-10% -$256 ﹤0.01% 835
2025
Q3 		$2.74K Buy
10
+1
+11% +$273 ﹤0.01% 783
2025
Q2 		$2.32K Buy
9
+3
+50% +$716 ﹤0.01% 612
2025
Q1 		$1.34K Buy
+6
New +$1.4K ﹤0.01% 696
2024
Q4 		– Sell
-71
Closed -$17.3K – 648
2024
Q3 		$17.3K Buy
+71
New +$15.9K 0.01% 199

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Aware Super
Aware Super Sydney, Australia $7.51B AUM
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
UniSuper Management
UniSuper Management Melbourne, Victoria, Australia $20.4B AUM 33.79% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

Highline Wealth Partners's RMD Position: Q3 2026 in Review

Highline Wealth Partners held its ResMed (RMD) position steady in Q3 2026 at 28 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Highline Wealth Partners first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $17.3K in Q3 2024. 279 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Highline Wealth Partners held 28 shares of ResMed worth $6.19K as of Q3 2026.
  • Highline Wealth Partners left its ResMed share count unchanged in Q3 2026.
  • ResMed made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #849 holding.
  • Highline Wealth Partners first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • Highline Wealth Partners's ResMed position peaked at $17.3K in Q3 2024.
  • 279 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.